Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FRA:E9Q'
s EV-to-EBIT Range Over the Past 10 Years
Min: -395.82 Med: 3.68 Max: 13.74
Current: 2.16
During the past 13 years, the highest EV-to-EBIT of Guangdong Kanghua Healthcare Group Co was 13.74. The lowest was -395.82. And the median was 3.68.
FRA:E9Q's EV-to-EBIT is ranked better than 94.61% of 482
companies
in the Healthcare Providers & Services industry
Industry Median: 14.965
vs FRA:E9Q: 2.16
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Guangdong Kanghua Healthcare Group Co's Enterprise Value for the quarter that ended in Dec. 2025 was €14.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Guangdong Kanghua Healthcare Group Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €19.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Kanghua Healthcare Group Co EV-to-EBIT Related Terms
Guangdong Kanghua Healthcare Group Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Kanghua Healthcare Group Co EV-to-EBIT Chart
For the Medical Care Facilities subindustry, Guangdong Kanghua Healthcare Group Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Kanghua Healthcare Group Co EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guangdong Kanghua Healthcare Group Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Guangdong Kanghua Healthcare Group Co's EV-to-EBIT falls into.
Guangdong Kanghua Healthcare Group Co's current Enterprise Value is €41.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Guangdong Kanghua Healthcare Group Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €19.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a EV-to-EBIT of 2.16 as of Sep. 15, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. This is 41% below median its historical median of 3.68. According to the industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #26 out of 482 companies in the Healthcare Providers & Services industry, placing it in the top 5.4%.
Is Guangdong Kanghua Healthcare Group Co's EV-to-EBIT too high?
Guangdong Kanghua Healthcare Group Co's current EV-to-EBIT of 2.16 is 41% below median its 10-year median of 3.68. The Healthcare Providers & Services industry median EV-to-EBIT is 14.97. Guangdong Kanghua Healthcare Group Co's value of 2.16 is 85.6% below this industry median. Based on the distribution chart, Guangdong Kanghua Healthcare Group Co ranks #26 out of 482 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Guangdong Kanghua Healthcare Group Co has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Kanghua Healthcare Group Co's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #26 out of 482 companies for EV-to-EBIT. This places Guangdong Kanghua Healthcare Group Co in the top 5% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 14.97. Guangdong Kanghua Healthcare Group Co's value of 2.16 is 85.6% below this benchmark. While the company's 10-year median is 3.68 vs. the industry median of 14.97, Guangdong Kanghua Healthcare Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 14.97, based on 482 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Kanghua Healthcare Group Co's current EV-to-EBIT of 2.16 is 85.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 14.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Kanghua Healthcare Group Co's current EV-to-EBIT is 2.16, which is 41% below median its own 10-year median of 3.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Kanghua Healthcare Group Co stock overvalued right now?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a current EV-to-EBIT of 2.16. The stock's GF Value™ is €0.20, compared to a current price of €0.19 — trading 7.5% below its estimated fair value. The current EV-to-EBIT is 2.16, which is 41% below median its 10-year median of 3.68 and 85.6% below the Healthcare Providers & Services industry median of 14.97. Guangdong Kanghua Healthcare Group Co's overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Guangdong Kanghua Healthcare Group Co (FRA:E9Q), the current EV-to-EBIT is 2.16 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Kanghua Healthcare Group Co stock appears to be undervalued.
The current stock price of €0.19 is trading 7.5% below its estimated GF Value™ of €0.20.
Key valuation signals for FRA:E9Q:
EV-to-EBIT: 2.16 (41% below median its 10-year median of 3.68)
GF Value™: €0.20 vs. price of €0.19 (7.5% below fair value)
Industry Position: 85.6% below the Healthcare Providers & Services median (#26 of 482)
No single metric tells the full story. See the FRA:E9Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangdong Kanghua Healthcare Group Co Ltd provides healthcare services. The reportable segments are as follows, The Hospital services segment, which generates majority revenue, includes the provision of hospital services including inpatient healthcare services, outpatient healthcare services, and physical examination services; Rehabilitation and other healthcare services including the provision of rehabilitation services; Elderly healthcare services include the provision of elderly healthcare services, including assisted living, adult daycare, longterm care, residential care and hospice care to the aged patients; and Haemodialysis services segment is principally engaged in the operation of haemodialysis outpatient centres. It generates all of its revenue from the PRC.
74GF Score
Get the complete analysis for FRA:E9Q
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E9Q has been successfully added to your 
